| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 11280 | 2012 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 7890 | 2016 |
| Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128· 9 million … L Abarca-Gómez, ZA Abdeen, ZA Hamid, NM Abu-Rmeileh, ... The lancet 390 (10113), 2627-2642, 2017 | 7794 | 2017 |
| Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19· 2 million participants NCD Risk Factor Collaboration Lancet (London, England) 387 (10026), 1377, 2016 | 5574 | 2016 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … S Abdalla, F Abd-Allah, MI Abdel Aziz The Lancet, 2015 | 5480 | 2015 |
| Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4· 4 million participants B Zhou, Y Lu, K Hajifathalian, J Bentham, M Di Cesare, G Danaei, H Bixby, ... The lancet 387 (10027), 1513-1530, 2016 | 4110 | 2016 |
| The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo … C Baigent, MJ Landray, C Reith, J Emberson, DC Wheeler, C Tomson, ... The Lancet 377 (9784), 2181-2192, 2011 | 2929 | 2011 |
| Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19· 1 million participants B Zhou, J Bentham, M Di Cesare, H Bixby, G Danaei, MJ Cowan, ... The Lancet 389 (10064), 37-55, 2017 | 2685 | 2017 |
| Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents E Di Angelantonio, SN Bhupathiraju, D Wormser, P Gao, S Kaptoge, ... The Lancet 388 (10046), 776-786, 2016 | 2637 | 2016 |
| New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk J Dupuis, C Langenberg, I Prokopenko, R Saxena, N Soranzo, ... Nature genetics 42 (2), 105-116, 2010 | 2495 | 2010 |
| Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 … B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ... The Lancet 398 (10304), 957-980, 2021 | 1929 | 2021 |
| The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke International Stroke Trial Collaborative Group The Lancet 349 (9065), 1569-1581, 1997 | 1833 | 1997 |
| Stroke in China: advances and challenges in epidemiology, prevention, and management S Wu, BO Wu, M Liu, Z Chen, W Wang, CS Anderson, P Sandercock, ... The Lancet Neurology 18 (4), 394-405, 2019 | 1183 | 2019 |
| Effects of aspirin for primary prevention in persons with diabetes mellitus ASCEND Study Collaborative Group New England Journal of Medicine 379 (16), 1529-1539, 2018 | 1095 | 2018 |
| China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up Z Chen, J Chen, R Collins, Y Guo, R Peto, F Wu, L Li International journal of epidemiology 40 (6), 1652-1666, 2011 | 910 | 2011 |
| Effects of anacetrapib in patients with atherosclerotic vascular disease HPS3/TIMI55–Reveal Collaborative Group New England Journal of Medicine 377 (13), 1217-1227, 2017 | 902 | 2017 |
| Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways RA Scott, V Lagou, RP Welch, E Wheeler, ME Montasser, J Luan, R Mägi, ... Nature genetics 44 (9), 991-1005, 2012 | 881 | 2012 |
| HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for … European heart journal 34 (17), 1279-1291, 2013 | 763 | 2013 |
| Effects of n− 3 fatty acid supplements in diabetes mellitus ASCEND Study Collaborative Group New England Journal of Medicine 379 (16), 1540-1550, 2018 | 727 | 2018 |
| Rising rural body-mass index is the main driver of the global obesity epidemic in adults Nature 569 (7755), 260-264, 2019 | 716 | 2019 |
